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Distal renal tubular acidosis (dRTA)
and bone histomorphometry
To the Editor: It was with great pleasure that we read the review
entitled ‘Nephrolithiasis-associated bone disease: pathogenesis and
treatment options’ by Sakhaee et al.1 Studies on an association
between distal renal tubular acidosis (dRTA), calcium nephro-
lithiasis, and bone histomorphometry are scarce. The authors
stated that no studies have been published in which bone
histomorphometry and dual-energy X-ray absorptiometry
have been used to link bone disease with dRTA. This is not
correct, because in this very jounal, Domrongkitchaiporn et al.2,3
published a series of small studies from Thailand—where the
incidence of dRTA is very high—on bone histology and bone
mineral density before and after correction of acidosis in dRTA
patients. They demonstrated that low bone mass levels, suppressed
bone formation rates, and osteoblastic and osteoclastic activity
were common ﬁndings in such patients. Correction of chronic
metabolic acidosis with alkaline therapy resulted in a marked
increase in bone formation. A further study from the same group
showed different degrees of impaired bone matrix mineralization
in dRTA patients and that alkaline therapy increased bone mass
through the restoration of bone mineral balance.4
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The Author Replies: Arampatzis et al.1 raise an important
point regarding our article entitled ‘Nephrolithiasis-
associated bone disease: pathogenesis and treatment
options’.2 I agree that short-term studies conducted in a
small number of patients have shown alkali treatment to be
effective in patients with distal renal tubular acidosis
(dRTA).3–5 However, two studies cited by Arampatzis et al.
showed bone mineral density (BMD) Z-scores at the L2–L4
spine (0.46±1.21 (ref. 3) and 0.4±1.2 (ref. 4)) were
within normal ranges. Moreover, Z-score at the total femur,
femoral neck, Ward’s triangle, and trochanter were all
normal.3,4 On the basis of mean age of these populations
(32.7±11.9 (ref. 3) and 31.6±11.1 (ref. 4)), the diagnosis of
osteopenia/osteoporosis would be more reliable on the basis
of Z-score as opposed to T-score, which is an inaccurate way
to assess BMD in a population of this age. Nonetheless, in
one study using T-scores, even BMD at the L2–L4 spine was
barely below normal, with a T-score of 1.24±1.46.3
Moreover, T-score at the total femur (0.36±1.32) and
femoral neck (0.55±1.64), two common sites for assess-
ment of bone loss, were both within normal ranges. Only the
Ward’s triangle, an uncommon site for the diagnosis of
osteopenia/osteoporosis, was osteopenic, with a T-score of
1.56±1.51.3 As noted, evidence of normal BMD excludes
the possibility of impaired bone mass. This is the reason we
indicated that there are no studies linking bone disease with
dRTA and kidney stones.
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